| 1.28 Data as of May 21 |  -0.02 / -1.54%Today’s Change | 0.67 Today|||52-Week Range 1.99 | +16.36% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $66.4M |
Company Description
Cardica, Inc. designs and manufactures proprietary stapling devices for surgical procedures. Its stapling technology is designed to minimize operating time and to enable minimally-invasive and robot-assisted surgeries. The company manufactures automated anastomosis, C-Port Distal Anastomosis and PAS-Port Proximal Anastomosis systems for coronary artery bypass graft surgery. Cardica is developing the Cardica Microcutter, a true multi-fire endoscopic stapling device designed to be used in a variety of procedures, including bariatric, thoracic and general surgery. The company was founded by Bernard A. Hausen and Stephen A. Yencho on October 15, 1997 and is headquartered in Redwood City, CA.
Employees
Shareholders
| Mutual fund holders | 8.70% |
| Other institutional | 26.37% |
| Individual stakeholders | 19.38% |
Top Executives
| Bernard A. Hausen, MD, PhD | President, CEO, Director & Chief Medical Officer |
| Frederick M. Bauer | Vice President-Manufacturing & Operations |
| Robert Y. Newell, IV, MBA | CFO, Secretary, VP & Head-Investor Relations |
| Bryan D. Knodel, PhD | Vice President-Research & Development |
| Lee Swanstrom, MD | Medical Director |
.
